I haven’t read the full report only the article and it is interesting to read as a patient, patient group leader and as a non-pharma reader,. I do think it important to share these reports so that people can read them no matter which area of the med care industry they are based in. FibroFlutters… Read More Pharma Intelligence | 2018 R&D Review: 5 Key Takeaways